Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Prednisone"" wg kryterium: Wszystkie pola


Tytuł:
Efficacy and safety of azathioprine plus prednisone versus prednisone alone as first-line treatment for antinuclear antibody-positive immune thrombocytopenia: a retrospective cohort study.
Autorzy:
Su J; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
Xu M; Department of Physical Examination, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
Dong Z; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
Wang Q; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
Ma L; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
Xiao P; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
Chen X; Department of Blood Rheumatism Immunology, The Second Affiliated Hospital of Xiamen Medical College, Xiamen, People's Republic of China.
Pokaż więcej
Źródło:
Hematology (Amsterdam, Netherlands) [Hematology] 2023 Dec; Vol. 28 (1), pp. 2196864.
Typ publikacji:
Journal Article
MeSH Terms:
Azathioprine*/adverse effects
Prednisone*/adverse effects
Purpura, Thrombocytopenic, Idiopathic*/drug therapy
Humans ; Antibodies, Antinuclear ; Immunosuppressive Agents ; Retrospective Studies ; Thrombocytopenia/drug therapy
Czasopismo naukowe
Tytuł:
Relationship Between LTA4H Promotor Polymorphism and Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome and Its Prevention With Prednisone.
Autorzy:
Stek, Cari (AUTHOR)
Shey, Muki (AUTHOR)
Mnika, Khuthala (AUTHOR)
Schutz, Charlotte (AUTHOR)
Thienemann, Friedrich (AUTHOR)
Wilkinson, Robert J (AUTHOR)
Lynen, Lutgarde (AUTHOR)
Meintjes, Graeme (AUTHOR)
Pokaż więcej
Źródło:
Open Forum Infectious Diseases. Jul2023, Vol. 10 Issue 7, p1-4. 4p.
Czasopismo naukowe
Tytuł:
Long-term efficacy and safety of leflunomide combined with low-dose prednisone in treatment of myasthenia gravis: a retrospective study
Autorzy:
Qiu, LiAff1, Aff2, Aff3
Chen, PeiAff1, Aff2, Aff3
Ou, ChangyiAff1, Aff2, Aff3
Deng, JuanAff1, Aff2, Aff3
Huang, ZhidongAff1, Aff2, Aff3
Lin, ZhongqiangAff1, Aff2, Aff3
Ma, QianAff1, Aff2, Aff3
Huang, XinAff1, Aff2, Aff3
Yu, LuAff1, Aff2, Aff3
Ran, HaoAff4, IDs1376002302367y_cor10
Liu, WeibinAff1, Aff2, Aff3, IDs1376002302367y_cor11
Pokaż więcej
Źródło:
Acta Neurologica Belgica. 124(1):175-182
Czasopismo naukowe
Tytuł:
Effect of pulsed intravenous methylprednisolone with alternative low-dose prednisone on high-risk IgA nephropathy: a 18-month prospective clinical trial.
Autorzy:
Li Y; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Fu R; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Gao J; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Wang L; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Duan Z; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Tian L; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Ge H; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Ma X; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Zhang Y; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Li K; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China.
Xu P; School of Medicine, Royal College of Surgeons in Ireland, 123 St Stephen's Green, Dublin 2, Ireland.
Tian X; Section of Nephrology, Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, 06520, USA. .
Chen Z; Department of Nephrology, The Second Affiliated Hospital of Xi'an Jiaotong University, 157 West Fifth Road, Xi'an, 710004, Shaanxi, China. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2022 Jan 07; Vol. 12 (1), pp. 255. Date of Electronic Publication: 2022 Jan 07.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Glomerulonephritis, IGA/*drug therapy
Glucocorticoids/*administration & dosage
Methylprednisolone/*administration & dosage
Prednisone/*administration & dosage
Proteinuria/*drug therapy
Administration, Intravenous ; Administration, Oral ; Adult ; Disease Progression ; Drug Tapering ; Drug Therapy, Combination ; Female ; Glomerulonephritis, IGA/diagnosis ; Glomerulonephritis, IGA/immunology ; Glucocorticoids/adverse effects ; Humans ; Kidney Failure, Chronic/immunology ; Kidney Failure, Chronic/prevention & control ; Male ; Methylprednisolone/adverse effects ; Prednisone/adverse effects ; Prospective Studies ; Proteinuria/diagnosis ; Proteinuria/immunology ; Pulse Therapy, Drug ; Remission Induction ; Risk Assessment ; Risk Factors ; Time Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Leflunomide plus low-dose prednisone in patients with progressive IgA nephropathy: a multicenter, prospective, randomized, open-labeled, and controlled trial.
Autorzy:
Ni Z; Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Zhang Z; Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Yu Z; Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Lu F; Department of Nephrology, Huashan Hospital, Fudan University, Shanghai, China.
Mei C; Department of Nephrology, Shanghai Changzheng Hospital, Second Military Medical University, Shanghai, China.
Ding X; Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China.
Yuan W; Department of Nephrology, Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.
Zhang W; Department of Nephrology, Shanghai Ninth People's Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Jiang G; Department of Nephrology, Xinhua Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Sun M; Department of Nephrology, Huadong Hospital, Fudan University, Shanghai, China.
He L; Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Deng Y; Department of Nephrology, Longhua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Pang H; Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Qian J; Department of Nephrology, Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Pokaż więcej
Źródło:
Renal failure [Ren Fail] 2021 Dec; Vol. 43 (1), pp. 1214-1221.
Typ publikacji:
Journal Article; Multicenter Study; Randomized Controlled Trial
MeSH Terms:
Glomerulonephritis, IGA/*drug therapy
Immunosuppressive Agents/*therapeutic use
Leflunomide/*therapeutic use
Prednisone/*therapeutic use
Proteinuria/*drug therapy
Adult ; China ; Creatinine/blood ; Drug Therapy, Combination ; Female ; Glomerular Filtration Rate ; Glomerulonephritis, IGA/complications ; Humans ; Kidney/physiopathology ; Male ; Middle Aged ; Prednisone/administration & dosage ; Prospective Studies ; Proteinuria/etiology ; Treatment Outcome ; Young Adult
Czasopismo naukowe
Tytuł:
Combined treatment of prednisone and hydroxychloroquine may improve outcomes of frozen embryo transfer in antinuclear antibody-positive patients undergoing IVF/ICSI treatment.
Autorzy:
Gao R; The Reproductive Medical Center, Department of Obstetrics and Gynecology, West China Second University Hospital, 198150Sichuan University, Chengdu, China.; West China School of Medicine, 198150Sichuan University, Chengdu, China.; Key Laboratory of Birth Defects and Related of Women and Children of Ministry of Education, West China Second University Hospital, 198150Sichuan University, Chengdu, China.
Deng W; Key Laboratory of Birth Defects and Related of Women and Children of Ministry of Education, West China Second University Hospital, 198150Sichuan University, Chengdu, China.; Information Management Department, West China Second University Hospital, 198150Sichuan University, Chengdu, China.
Meng C; Key Laboratory of Birth Defects and Related of Women and Children of Ministry of Education, West China Second University Hospital, 198150Sichuan University, Chengdu, China.; Department of Obstetrics and Gynecology, West China Second University Hospital, 198150Sichuan University, Chengdu, China.
Cheng K; Department of Outpatients, West China Second University Hospital, 198150Sichuan University, Chengdu, China.
Zeng X; The Reproductive Medical Center, Department of Obstetrics and Gynecology, West China Second University Hospital, 198150Sichuan University, Chengdu, China.; Key Laboratory of Birth Defects and Related of Women and Children of Ministry of Education, West China Second University Hospital, 198150Sichuan University, Chengdu, China.
Qin L; The Reproductive Medical Center, Department of Obstetrics and Gynecology, West China Second University Hospital, 198150Sichuan University, Chengdu, China.; Key Laboratory of Birth Defects and Related of Women and Children of Ministry of Education, West China Second University Hospital, 198150Sichuan University, Chengdu, China.
Pokaż więcej
Źródło:
Lupus [Lupus] 2021 Dec; Vol. 30 (14), pp. 2213-2220. Date of Electronic Publication: 2021 Dec 13.
Typ publikacji:
Journal Article
MeSH Terms:
Abortion, Spontaneous*
Lupus Erythematosus, Systemic*/drug therapy
Hydroxychloroquine/*pharmacology
Prednisone/*pharmacology
Antibodies, Antinuclear ; Embryo Transfer ; Female ; Fertilization in Vitro ; Humans ; Hydroxychloroquine/chemistry ; Ovulation Induction ; Prednisone/chemistry ; Pregnancy ; Pregnancy Rate ; Retrospective Studies ; Sperm Injections, Intracytoplasmic
Czasopismo naukowe
Tytuł:
Toxic effect window of ovarian development in female offspring mice induced by prenatal prednisone exposure with different doses and time
Autorzy:
Huang, JingAff1, Aff3, Aff5
Wu, TianchengAff1, Aff5
Li, YatingAff1, Aff5
Zhang, YuanzhenAff1, Aff5
Yu, XingjiangAff6, IDs13048023011488_cor5
Xu, DanAff4, Aff5, IDs13048023011488_cor6
Wang, HuiAff1, Aff2, Aff5, IDs13048023011488_cor7
Pokaż więcej
Źródło:
Journal of Ovarian Research. 16(1)
Czasopismo naukowe
Tytuł:
Phase Ib trial of reformulated niclosamide with abiraterone/prednisone in men with castration-resistant prostate cancer.
Autorzy:
Parikh M; Division of Hematology Oncology, Department of Internal Medicine, School of Medicine, University of California, Davis, USA.
Liu C; Department of Urologic Surgery, School of Medicine, University of California, Davis, USA.
Wu CY; Department of Biochemistry and Molecular Medicine, School of Medicine, University of California, Davis, USA.
Evans CP; Department of Urologic Surgery, School of Medicine, University of California, Davis, USA.
Dall'Era M; Department of Urologic Surgery, School of Medicine, University of California, Davis, USA.
Robles D; Office of Clinical Research, UC Davis Comprehensive Cancer Center, Davis, USA.
Lara PN; Division of Hematology Oncology, Department of Internal Medicine, School of Medicine, University of California, Davis, USA.
Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, USA.
Gao AC; Department of Urologic Surgery, School of Medicine, University of California, Davis, USA. .; University of California, 4501 X Street, Suite 3016, Sacramento, CA, 95817, USA. .
Pan CX; Division of Hematology Oncology, Department of Internal Medicine, School of Medicine, University of California, Davis, USA. chongxian_.; Harvard Medical School, VA Boston Healthcare System, 1400 VFW Parkway, West Roxbury, MA, 02132, USA. chongxian_.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2021 Mar 18; Vol. 11 (1), pp. 6377. Date of Electronic Publication: 2021 Mar 18.
Typ publikacji:
Clinical Trial, Phase I; Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Androstenes/*administration & dosage
Niclosamide/*administration & dosage
Prednisone/*administration & dosage
Prostatic Neoplasms, Castration-Resistant/*drug therapy
Aged ; Androstenes/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Disease-Free Survival ; Drug-Related Side Effects and Adverse Reactions/classification ; Drug-Related Side Effects and Adverse Reactions/pathology ; Humans ; Male ; Maximum Tolerated Dose ; Middle Aged ; Niclosamide/adverse effects ; Prednisone/adverse effects ; Prostate-Specific Antigen/blood ; Prostatic Neoplasms, Castration-Resistant/blood ; Prostatic Neoplasms, Castration-Resistant/pathology
Czasopismo naukowe
Tytuł:
Cabozantinib plus docetaxel and prednisone in metastatic castration-resistant prostate cancer.
Autorzy:
Madan RA; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Karzai FH; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Al Harthy M; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Petrylak DP; Yale School of Medicine, New Haven, CT, USA.
Kim JW; Yale School of Medicine, New Haven, CT, USA.
Arlen PM; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Rosner I; Center for Prostate Disease Research, Walter Reed National Military Medical Center, Bethesda, MD, USA.
Theoret MR; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Cordes L; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Bilusic M; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Peer CJ; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Dawson NA; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, USA.
Couvillon A; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Hankin A; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Williams M; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Chun G; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Owens H; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Marte JL; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Lee MJ; Developmental Therapeutics Branch, NCI, Bethesda, MD, USA.
Tomita Y; Developmental Therapeutics Branch, NCI, Bethesda, MD, USA.
Yuno A; Developmental Therapeutics Branch, NCI, Bethesda, MD, USA.
Trepel JB; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Lee S; Developmental Therapeutics Branch, NCI, Bethesda, MD, USA.
Steinberg SM; Biostatistics and Data Management Section, Center for Cancer Research, NCI, Bethesda, MD, USA.
Gulley JL; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Figg WD; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Dahut WL; Genitourinary Malignancies Branch, NCI, Bethesda, MD, USA.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2021 Apr; Vol. 127 (4), pp. 435-444. Date of Electronic Publication: 2020 Oct 23.
Typ publikacji:
Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Intramural
MeSH Terms:
Anilides/*administration & dosage
Antineoplastic Agents/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Docetaxel/*administration & dosage
Prednisone/*administration & dosage
Prostatic Neoplasms, Castration-Resistant/*drug therapy
Pyridines/*administration & dosage
Aged ; Aged, 80 and over ; Anilides/adverse effects ; Antineoplastic Agents/adverse effects ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Docetaxel/adverse effects ; Humans ; Male ; Middle Aged ; Neoplasm Metastasis ; Prednisone/adverse effects ; Prostatic Neoplasms, Castration-Resistant/pathology ; Pyridines/adverse effects ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Adjunct prednisone in community-acquired pneumonia: 180-day outcome of a multicentre, double-blind, randomized, placebo-controlled trial
Autorzy:
Blum, Claudine A.Aff1, Aff2, Aff3, IDs1289002302794w_cor1
Roethlisberger, Eva A.
Cesana-Nigro, NicoleAff1, Aff4
Winzeler, Bettina
Rodondi, NicolasAff5, Aff6
Blum, Manuel R.Aff5, Aff6
Briel, MatthiasAff7, Aff8
Mueller, Beat
Christ-Crain, Mirjam
Schuetz, Philipp
Pokaż więcej
Źródło:
BMC Pulmonary Medicine. 23(1)
Czasopismo naukowe
Tytuł:
Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy.
Autorzy:
Guo Y; Department of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.
Wu X; Department of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.
Liu L; Department of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.
Zhang H; Department of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.
Yang L; Department of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.
Chen W; Department of Nephrology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, People's Republic of China.
Pokaż więcej
Źródło:
Renal failure [Ren Fail] 2020 Nov; Vol. 42 (1), pp. 122-130.
Typ publikacji:
Journal Article; Randomized Controlled Trial
MeSH Terms:
Glomerulonephritis, Membranous/*complications
Glomerulonephritis, Membranous/*drug therapy
Leflunomide/*therapeutic use
Nephrotic Syndrome/*complications
Prednisone/*therapeutic use
Adult ; Autoantibodies/blood ; Biomarkers/blood ; Cyclophosphamide/therapeutic use ; Drug Therapy, Combination ; Female ; Humans ; Immunosuppressive Agents/therapeutic use ; Leflunomide/adverse effects ; Male ; Middle Aged ; Prednisone/adverse effects ; Proteinuria/drug therapy ; Receptors, Phospholipase A2/immunology ; Remission Induction ; Serum Albumin
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies